Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

Antonio Bertolotto(Neuroscience Institute), Simona Malucchi(Ospedale San Luigi Gonzaga), Maria Troiano(University of Bari Aldo Moro), Lucia Moiola(Vita-Salute San Raffaele University), Maria Giovanna Marrosu(University of Cagliari), Luigi Grimaldi(Fondazione Istituto G. Giglio di Cefalù), Alessandra Lugaresi(Istituto delle Scienze Neurologiche di Bologna), Ruggero Capra(Presidio Ospedaliero), Maria Pia Amato(University of Florence), Chiara Mancinelli(Sapienza University of Rome), Marco Salvetti(Istituto Neurologico Mediterraneo), Luisa Imberti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Elisabetta Capello(Ospedale Policlinico San Martino), Damiano Paolicelli(University of Bari Aldo Moro), Luigina Musu(ATS Sardegna (Italy)), Francesco Patti(University of Catania), Marco Capobianco(Ospedale San Luigi Gonzaga), Silvia Rossi, Silvia Romano, Carlo Pozzilli(Sapienza University of Rome), Antonio Gallo(University of Campania "Luigi Vanvitelli"), Enrico Montanari(University of Ferrara), Maria di Ioia(Associazione Italiana Sclerosi Multipla), Maria Rosaria Tola(University of Ferrara), Diego Centonze(University of Rome Tor Vergata), Gioachino Tedeschi(University of Campania "Luigi Vanvitelli"), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Neurological Sciences
December 28, 2013
Cited by 37


Related Papers